Protein expression profiling of endometrial malignancies reveals a new tumor marker: Chaperonin 10

Journal of Proteome Research

Volumn 3, Issue 3, 2004, Pages 636-643

  Yang, Eric C C ^a,e   Guo, Jingzhong ^a   Diehl, Georg ^a   DeSouza, Leroi ^a   Rodrigues, Mary Joe ^b   Romaschin, Alexander D ^c,d   Colgan, Terence J ^b,d   Siu, K W Michael ^a  

^a YORK UNIVERSITY   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Chaperonin 10; Endometrial carcinoma; MALDI; Mass spectrometry; Protein discovery; Protein identification; SELDI; Tumor marker

Indexed keywords

CHAPERONIN; TUMOR MARKER;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ION EXCHANGE CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN EXPRESSION PROFILING; PROTEIN PURIFICATION; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; WESTERN BLOTTING;

CHAPERONIN 10; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 3042552506     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr049975z     Document Type: Article

References (44)

1. National Cancer Institute of Canada: Canadian Cancer Statistics 2003, Toronto, Canada, 2003 [serial online] April 2003 [cited 2003 Oct 16]; Available from: URL: http://www.bc.cancer.ca/vgn/images/portal/cit_776/61/38/ 56158640niw_stats_en.pdf
2. American Cancer Society. Statistics. [serial online] 2003 [cited 2003 Oct 16]; Available from: URL: http://www.cancer.org/docroot/STT/stt_0.asp
3. Rose, P. G. Endometrial carcinoma. New Engl. J. Med. 1996, 335, 640-649.
4. Agboola, O. O.; Grunfeld, E.; Coyle, D.; Perry, G. A. Costs and benefits of routine follow-up after curative treatment for endometrial cancer. CMAJ 1997, 157, 879-886.
5. Duffy, M. J. Clinical uses of tumor markers: a critical review. Crit. Rev. Clin. Lab. Sci. 2001, 38, 225-262.
6. Byrjalsen, I.; Mose Larsen, P.; Fey, S. J.; Nilas, L.; Larsen, M. R.; Christiansen, C. Two-dimensional gel analysis of human endometrial proteins: characterization of proteins with increased expression in hyperplasia and adenocarcinoma. Mol. Hum. Reprod. 1999, 5, 748-756.
7. Chambers, G.; Lawrie, L.; Cash, P.; Murray, G. I. Proteomics: a new approach to the study of disease. J. Pathol. 2000, 192, 280-288.
8. Peng, J.; Gygi, S. P. Proteomics: the move to mixtures. J. Mass Spectrom. 2001, 36, 1083-1091.
9. Wu, W.; Hu, W.; Kavanagh, J. J. Proteomics in cancer research. Int. J. Gynecol. Cancer 2002, 12, 409-423.
10. Bryant-Greenwood, P. K.; Petricoin, E. F. III; Abati, A.; Liotta, L. High-Throughput Proteomic Analysis of Microdissected Cytological Specimens Yields Distinct Expression Profiles of Follicular vs Papillary Thyroid Carcinomas. Mod. Pathol. 2000, 13, 30A
11. Jones, M. B.; Krutzsch, H.; Shu, H.; Zhao, Y.; Liotta, L. A.; Kohn, E. C.; Petricoin, E. F. III Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer. Proteomics 2002, 2, 76-84.
12. Knezevic, V.; Leethanakul, C.; Bichsel, V. E.; Worth, I. M.; Prabhu, V. V.; Gutkind, J. S.; Liotta, L. A.; Munson, P. J.; Petricoin, E. F. III; Krizman, D. B. Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics 2001, 1, 1271-1278.
13. Paweletz, C. P.; Gillespie, J. W.; Ornstein, D. K.; Simone, N. L.; Brown, M. R.; Cole, K. A.; Wang, Q.-H.; Huang, J.; Hu, N.; Yip, T.-T.; Rich, W. E.; Kohn, E. C.; Linehan, W. M.; Weber, T.; Taylor, P.; Emmert-Buck, M. R.; Liotta, L. A.; Petricoin, E. F., III Rapid Protein Display Profiling of Cancer Progression Directly From Human Tissue Using a Protein Biochip. Drug Dev. Res. 2000, 49, 34-42.
14. Petricoin, E. F.; Ardekani, A. M.; Hitt, B. A.; Levine, P. J.; Fusaro, V. A.; Steinberg, S. M.; Mills, G. B.; Simone, C.; Fishman, D. A.; Kohn, E. C.; Liotta, L. A. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002, 359, 572-577.
15. Vlahou, A.; Schellhammer, P. F.; Mendrinos, S.; Patel, K.; Kondylis, F. I.; Gong, L.; Nasim, S.; Wright, J. G. Jr. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am. J. Pathol. 2001, 158, 1491-1502.
16. Wright, G. L. Jr.; Cazares, L. H.; Leung, S.-M.; Nasim, S.; Adam, B.-L.; Yip, T.-T.; Schellhammer, P. F.; Gong, L.; Vlahou, A. Proteinchip surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer Prostatic Dis. 1999, 2, 264-276.
17. Wulfkuhle, J. D.; McLean, K. C.; Paweletz, C. P.; Sgroi, D. C.; Trock, B. J.; Steeg, P. S.; Petricoin, E. F. III New approaches to proteomic analysis of breast cancer. Proteomics 2001, 1, 1205-1215.
18. Liotta, L. A.; Ferrari, M.; Petricoin, E. Written in blood. Nature 2003, 425, 905.
19. nd Annual & IUBIMB XIX World Congress, Montreal, Quebec, October 8-11, 2003.
20. Marshall, J.; Kupchak, P.; Zhu, W.; Yantha, J.; Vrees, T.; Furesz, S.; Jacks, K.; Smith, C.; Kireeva, I.; Zhang, R.; Takahashi, M.; Stanton, E.; Jackowski, G. Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction. J. Proteome Res. 2003, 2, 361-372.
21. Kurman, R. J., Ed Blaustein's Pathology of the Female Genital Tract, 5th ed.; New York, Springer-Verlag: 2002.
22. Cavanagh, A. C.; Morton, H. The purification of early-pregnancy factor to homogeneity from human platelets and identification as chaperonin 10. Eur. J. Biochem. 1994, 222, 551-560.
23. Inoue, M. Current molecular aspects of the carcinogenesis of the uterine endometrium. Int. J. Gynecol. Cancer 2001, 11, 339-348.
24. Mutter, G. L.; Baak, J. P.; Fitzgerald, J. T.; Gray, R.; Neuberg, D.; Kust, G. A.; Gentleman, R.; Gullans, S. R.; Wei, L. J.; Wilcox, M. Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation. Gynecol. Oncol. 2001, 83, 177-185.
25. Wulfkuhle, J. D.; Liotta, L. A.; Petricoin, E. F. Proteomic applications for the early detection of cancer. Nat. Rev. Cancer 2003, 3, 267-275.
26. Walch, A.; Komminoth, P.; Hutzler, P.; Aubele, M.; Hofler, H.; Werner, M. Microdissection of tissue sections: application to the molecular genetic characterisation of premalignant lesions. Pathobiology 2000, 68, 9-17.
27. Sugiyama, Y.; Sugiyama, K.; Hirai, Y.; Akiyama, F.; Hasumi, K. Microdissection is essential for gene expression profiling of clinically resected cancer tissues. Am. J. Clin. Pathol. 2002, 117, 109-116.
28. Batorfi, J.; Ye, B.; Mok, S. C.; Cseh, I.; Berkowitz, R. S.; Fulop, V. Protein profiling of complete mole and normal placenta using ProteinChip analysis on laser capture microdissected cells. Gynecol. Oncol. 2003, 88, 424-428.
29. Wright, G. L.; Cazares, L. H.; Leung, S. M.; Nasim, S.; Adam, B. L.; Yip, T. T.; Schellhammer, P. F.; Gong, L.; Vlahou, A. Proteinchip surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures. Prostate Cancer Prostatic Dis. 1999, 2, 264-276.
30. von Eggeling, F.; Davies, H.; Lomas, L.; Fiedler, W.; Junker, K.; Claussen, U.; Ernst, G. Tissue-specific microdissection coupled with ProteinChip array technologies: applications in cancer research. BioTechniques 2000, 29, 1066-1070.
31. Somodevilla-Torres, M. J.; Hillyard, N. C.; Morton, H.; Alewood, D.; Halliday, J. A.; Alewood, P. F.; Vesey, D. A.; Walsh, M. D.; Cavanagh, A. C. Preparation and characterization of polyclonal antibodies against human chaperonin 10. Cell Stress Chaperones 2000, 5, 14-20.
32. Cornford, P. A.; Dodson, A. R.; Parsons, K. F.; Desmond, A. D.; Woolfenden, A.; Fordham, M.; Neoptolemos, J. P.; Ke, Y.; Foster, C. S. Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res. 2000, 60, 7099-7105.
33. Quinn, K. A.; Morton, H. Effect of monoclonal antibodies to early pregnancy factor (EPF) on the in vivo growth of transplantable murine tumours. Cancer Immunol. Immunother. 1992, 34, 265-271.
34. Cappello, F.; Bellafiore, M.; David, S.; Anzalone, R.; Zummo, G. Ten kilodalton heat shock protein (HSP10) is overexpressed during carcinogenesis of large bowel and uterine exocervix. Cancer Lett. 2003, 196, 35-41.
35. Kato, S.; Kato, M.; Hirano, A.; Takikawa, M.; Ohama, E. The immunohistochemical expression of stress-response protein (srp) 60 in human brain tumours: relationship of srp 60 to the other five srps, proliferating cell nuclear antigen and p53 protein. Histol. Histopathol. 2001, 16, 809-820.
36. Tabibzadeh, S.; Kong, Q. F.; Satyaswaroop, P. G.; Babaknia, A. Heat shock proteins in human endometrium throughout the menstrual cycle. Hum. Reprod. 1996, 11, 633-640.
37. Shah, M.; Stanek, J.; Handwerger, S. Differential localization of heat shock proteins 90, 70, 60, and 27 in human decidua and placenta during pregnancy. Histochem. J. 1998, 30, 509-518.
38. Noonan, F. P.; Halliday, W. J.; Morton, H.; Clunie, G. J. Early pregnancy factor is immunosuppressive. Nature 1979, 278, 649-651.
39. Athanasas-Platsis, S.; Quinn, K. A.; Wong, T. Y.; Rolfe, B. E.; Cavanagh, A. C.; Morton, H. Passive immunization of pregnant mice against early pregnancy factor causes loss of embryonic viability. J . Reprod. Fertil. 1989, 87, 495-502.
40. Athanasas-Platsis, S.; Morton, H.; Dunglison, G. F.; Kaye, P. L. Antibodies to early pregnancy factor retard embryonic development in mice in vivo. J. Reprod. Fertil. 1991, 92, 443-451.
41. Athanasas-Platsis, S.; Corcoran, C. M.; Kaye, P. L.; Cavanagh, A. C.; Morton, H. Early pregnancy factor is required at two important stages of embryonic development in the mouse. Am. J. Reprod. Immunol. 2000, 43, 223-233.
42. Quinn, K. A.; Cavanagh, A. C.; Hillyard, N. C.; McKay, D. A.; Morton, H. Early pregnancy factor in liver regeneration after partial hepatectomy in rats: relationship with chaperonin 10. Hepatology 1994, 20, 1294-1302.
43. Quinn, K. A. Active immunization with EPF suppresses the formation of immune ascites in BALB/c mice. Immunol. Cell. Biol. 1991, 69 (Pt 1), 1-6.
44. Fan, X.; Yan, L.; Jia, S.; Ma, A.; Qiao, C. A study of early pregnancy factor activity in the sera of women with trophoblastic tumor. Am. J. Reprod. Immunol. 1999, 41, 204-208.